Is primary prevention implantable cardioverter defibrillator implantation still warranted in the era of modern heart failure therapy? - a retrospective real-world cohort analysis

31 March 2025 (08:00 - 17:45)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Doctor Andrea Schlichting

Asklepios St. Georg Clinic, Hamburg (Germany)

146 More presentations in this session

Presentation thumbnail

Impact of ICD and CRT-D implantation on survival in ischemic and non-ischemic cardiomyopathy: a single-center croatian retrospective cohort study and comparative insights with the DANISH trial

Assistant Professor M. Puljevic (Zagreb, HR)

Presentation thumbnail

Do the longer leadless pacemakers with helix screws affect tricuspid regurgitation after pacemaker implantation?

Presentation thumbnail

Classification of atrial fibrillation burden pattern in cardiac implantable electronic devices

Mr S. Majumder (Minneapolis, US)

Abstract Slides Video

Presentation thumbnail

Life-threatening arrhythmia in patients with suspected acute myocarditis

Miss K. Bulatova (Basel, CH)

Abstract Slides Video

Presentation thumbnail

Early outcomes of left bundle branch area pacing upgrade in pediatric pacing-induced cardiomyopathy

Mr Y. Turubayev (Astana, KZ)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

The Event

Event poster

EHRA 2025

31 March 2025 08:00 CET

You may be interested in

Congress Session

Debate on primary prevention in ICD therapy

Congress Session

Implantable cardioverter defibrillator therapy

Congress Session

Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources